Population Pharmacokinetic and Concentration-QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies

Statistical Characteristics of Moxifloxacin-Induced QTc Effect

(2010) Lihan K. Yan et al.   Journal of Biopharmaceutical Statistics

Randomized, Double-Blind, Crossover Study to Investigate the Effect of Rivaroxaban on QT-Interval Prolongation

(2009) Dagmar Kubitza et al.   DRUG SAFETY

Electrocardiographic QTc Changes Due to Moxifloxacin Infusion

(2009) Marek Malik et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects

(2008) Ruth Dixon et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT Studies

(2008) DM Bloomfield et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Testing for Positive Control Activity in a Thorough QTc Study∗

(2008) Joanne Zhang   Journal of Biopharmaceutical Statistics

Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval

(2008) M. Iwamoto et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Concentration-QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review

(2007) Christin E. Garnett et al.   JOURNAL OF CLINICAL PHARMACOLOGY